These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 17468158)

  • 1. Safe practices and financial considerations in using oral chemotherapeutic agents.
    Bartel SB
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S8-S14. PubMed ID: 17468158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
    Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
    J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety considerations and safe handling of oral chemotherapy agents.
    Griffin E
    Clin J Oncol Nurs; 2003; 7(6 Suppl):25-9. PubMed ID: 14705497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reimbursement and patient assistance programs for oral chemotherapy agents.
    Wilkinson K
    Clin J Oncol Nurs; 2003; 7(6 Suppl):31-6. PubMed ID: 14705498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Templates of patient brochures for the preparation, administration and safe-handling of oral chemotherapy.
    Siden R; Kem R; Ostrenga A; Nicksy D; Bernhardt B; Bartholomew J
    J Oncol Pharm Pract; 2014 Jun; 20(3):217-24. PubMed ID: 23748870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Medicare Prescription Drug Improvement and Modernization Act and the delivery of cancer chemotherapy.
    Downs C
    Am J Health Syst Pharm; 2007 Aug; 64(15 Suppl 10):S13-5; quiz S21-S23. PubMed ID: 17646548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-office dispensing of oral oncolytics: a continuity of care and cost mitigation model for cancer patients.
    Egerton NJ
    Am J Manag Care; 2016 Mar; 22(4 Suppl):s99-s103. PubMed ID: 27270161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe handling and administration considerations of oral anticancer agents in the clinical and home setting.
    Lester J
    Clin J Oncol Nurs; 2012 Dec; 16(6):E192-7. PubMed ID: 23178361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents.
    Bedell CH
    Clin J Oncol Nurs; 2003; 7(6 Suppl):5-9. PubMed ID: 14705494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral Chemotherapy: A Home Safety Educational Framework for Healthcare Providers, Patients, and Caregivers.
    Huff C
    Clin J Oncol Nurs; 2020 Feb; 24(1):22-30. PubMed ID: 31961842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral agents for cancer: safety challenges and recommendations.
    Rudnitzki T; McMahon D
    Clin J Oncol Nurs; 2015 Jun; 19(3 Suppl):41-6. PubMed ID: 26030392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions and experiences of patients receiving oral chemotherapy.
    Simchowitz B; Shiman L; Spencer J; Brouillard D; Gross A; Connor M; Weingart SN
    Clin J Oncol Nurs; 2010 Aug; 14(4):447-53. PubMed ID: 20682500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current issues in pharmaceutical reimbursement.
    Fijalka S; Fye D; Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S11-26. PubMed ID: 18192243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
    Lam MS
    Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical care program for onco-hematologic outpatients: safety, efficiency and patient satisfaction.
    Ribed A; Romero-Jiménez RM; Escudero-Vilaplana V; Iglesias-Peinado I; Herranz-Alonso A; Codina C; Sanjurjo-Sáez M
    Int J Clin Pharm; 2016 Apr; 38(2):280-8. PubMed ID: 26715547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-handling practices of outpatient and office-based oncology nurses.
    Martin S; Larson E
    Oncol Nurs Forum; 2003; 30(4):575-81. PubMed ID: 12861318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of electronic health record implementation on pharmacist interventions related to oral chemotherapy management.
    Finn A; Bondarenka C; Edwards K; Hartwell R; Letton C; Perez A
    J Oncol Pharm Pract; 2017 Dec; 23(8):563-574. PubMed ID: 27573921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoeconomic and clinical outcomes in oncology using oral chemotherapy.
    Navarro RP; Morrow T; Baran R
    Manag Care Interface; 2002 Jul; 15(7):55-62. PubMed ID: 12143298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient assistance programs and patient advocacy foundations: alternatives for obtaining prescription medications when insurance fails.
    Johnson PE
    Am J Health Syst Pharm; 2006 Nov; 63(21 Suppl 7):S13-7. PubMed ID: 17057055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of the changing paradigm in cancer treatment: oral chemotherapy.
    Aisner J
    Am J Health Syst Pharm; 2007 May; 64(9 Suppl 5):S4-7. PubMed ID: 17468157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.